Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SamCurt
    Member
    • May 2010
    • 40

    #1

    Is FPKM a good substitute for microarray expression levels?

    A few months ago I have asked here whether FPKMs in general can be used like microarray expression levels. While Dr Anders has kindly gave his opinion (that some transformation (such as log) might be needed), I wonder if this holds true for any other kind of analyses that takes microarray expression as input?

    Specifically, I am planning on performing Quantitative Trait Transcript (QTT) and/or WCGNA on these data, but I didn't see any discussion on their applicability anywhere.

    Unfortunately, the papers involved in these methods seemed to be confined to microarray expressions.

    On close inspection, I have noticed QTT basically relies on standard Pearson correlation between two linear regression models. I haven't completely reviewed about WCGNA's algorithm, but the adjacency is also based on Pearson correlation.

    Of course Pearson's rho test is based on linearity. But does that make the usage of FPKMs in these methods inappropriate?

    Thanks for the answer in advance!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...